BEX4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.404000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.100600E-01
Normal-vs-Stage2
1.037960E-01
Normal-vs-Stage3
2.421800E-02
Normal-vs-Stage4
3.679800E-02
Stage1-vs-Stage2
2.483200E-01
Stage1-vs-Stage3
2.234200E-01
Stage1-vs-Stage4
2.329600E-01
Stage2-vs-Stage3
8.032200E-01
Stage2-vs-Stage4
8.403800E-01
Stage3-vs-Stage4
9.525400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.936600E-01
Normal-vs-AfricanAmerican
1.805830E-02
Normal-vs-Asian
6.955800E-03
Caucasian-vs-AfricanAmerican
6.592400E-01
Caucasian-vs-Asian
2.166000E-02
AfricanAmerican-vs-Asian
1.062560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.322800E-01
Normal-vs-Female
4.668200E-01
Male-vs-Female
7.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.709600E-01
Normal-vs-Age(41-60Yrs)
5.790600E-01
Normal-vs-Age(61-80Yrs)
3.712200E-01
Normal-vs-Age(81-100Yrs)
7.577400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.254000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.711600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.164200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.683200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.116200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.127000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.802000E-03
Normal-vs-Daily Drinker
3.370800E-01
Normal-vs-Weekly Drinker
1.883060E-03
Normal-vs-Occasional Drinker
4.305000E-01
Normal-vs-Social Drinker
3.983200E-01
Non Drinker-vs-Daily Drinker
2.272800E-01
Non Drinker-vs-Weekly Drinker
9.665000E-01
Non Drinker-vs-Occasional Drinker
2.637200E-01
Non Drinker-vs-Social Drinker
2.655200E-01
Daily Drinker-vs-Weekly Drinker
2.262800E-01
Daily Drinker-vs-Occasional Drinker
9.605800E-01
Daily Drinker-vs-Social Drinker
9.827600E-01
Weekly Drinker-vs-Occasional Drinker
2.623600E-01
Weekly Drinker-vs-Social Drinker
2.642800E-01
Occasional Drinker-vs-Social Drinker
9.791800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.877200E-01
Normal-vs-Grade 2
2.576400E-01
Normal-vs-Grade 3
3.091200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.843880E-02
Grade 1-vs-Grade 3
1.474160E-02
Grade 1-vs-Grade 4
3.877200E-01
Grade 2-vs-Grade 3
6.121800E-01
Grade 2-vs-Grade 4
2.576400E-01
Grade 3-vs-Grade 4
3.091200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.466060E-02
Normal-vs-NonDiabetic
3.733700E-02
Diabetic-vs-NonDiabetic
1.270230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.309820E-02
Normal-vs-NoPancreatitis
4.293400E-01
Pancreatitis-vs-NoPancreatitis
1.906790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.115800E-01
Normal-vs-N1
1.398550E-01
N0-vs-N1
1.240020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.565130E-04
Normal-vs-TP53-NonMutant
7.798000E-01
TP53-Mutant-vs-TP53-NonMutant
9.81799999999478E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
